XM无法为美国居民提供服务。

Becton Dickinson agrees to settle about 38,000 hernia mesh suits



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Becton Dickinson agrees to settle about 38,000 hernia mesh suits</title></head><body>

By Brendan Pierson

Oct 3 (Reuters) -Becton Dickinson BDX.N has agreed to resolve nearly all U.S. lawsuits by people who say they were injured by its hernia repair mesh, about 38,000 cases, in an unusual settlement overseen jointly by state and federal courts, promising an end to litigation stretching back almost two decades.

Terms of the settlement, which the company announced on Wednesday, were not disclosed. BD said the amount was a "large majority" of what it had already set aside for product liability litigation, which was $1.7 billion according to its last quarterly report.

The company said the payouts would take place over several years, with the first before the end of this year.

Almost 25,000 of the cases are centralized in federal court in Columbus, Ohio, with the remainder centralized in state court in Providence, Rhode Island. Plaintiffs will be able to opt out of the settlement, though plaintiffs' lawyers said they expected a very high rate of participation.

BD said it did not admit wrongdoing and would defend itself against any cases by plaintiffs who do not take part in the settlement.

Tim O'Brien of Levin Papantonio and Kelsey Stokes of Fleming Nolen & Jez, lead lawyers for the federal court plaintiffs, said in a joint statement that they were "pleased that the global resolution and resulting process will afford so many individuals a measure of justice."

Don Migliori of Motley Rice, a lead attorney for the plaintiffs in Rhode Island, said that while there have been combined state and federal settlements in mass tort litigation before, the degree of coordination between federal and state courts and attorneys in the mesh cases was unique.

Special masters appointed by both courts will work together to administer claims, and the claims process will be substantially the same for plaintiffs no matter where their case is pending, according to Migliori.

"I think this is the first truly comprehensive effort to have the two judges work together," he said.

The first hernia mesh cases were filed in 2006 in state court in Rhode Island, where hernia mesh maker Davol was headquartered. BD bought Davol's parent company, C.R. Bard, in 2017.

The products at issue are flexible mesh made of polypropylene that are implanted to repair hernias. Plaintiffs say their mesh implants degraded in their bodies and caused a variety of injuries, including infection, chronic pain and organ damage.

Of four cases that went to trial, three resulted in verdicts for the plaintiffs - for $255,000 and $500,000 in federal court, and $4.8 million in state court. The company won another trial, which was in federal court.

The federal MDL is In re: Davol Inc/C.R. Bard Inc Polypropylene Hernia Mesh Products Liability Litigation, U.S. District Court for the Southern District of Ohio, No. 18-md-02846.

The Rhode Island litigation is In re: Davol/C.R. Bard hernia mesh multi-case management, Rhode Island Superior Court, No. PC-2018-9999.

For the plaintiffs: Tim O'Brien of Levin Papantonio and Kelsey Stokes, Fleming Nolen & Jez in Ohio; Don Migliori and Jonathan Orent of Motley Rice in Rhode Island

For BD: Michael Brown of Reed Smith


Read more:

R.I. jury orders Becton Dickinson to pay $4.8 mln in hernia mesh trial

Becton Dickinson ordered to pay $255k in hernia mesh trial


(Reporting By Brendan Pierson in New York)

</body></html>

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明